NVO241122P102000
- 0.03
- 0.000.00%
Novo-Nordisk A/S Newsroom
Antag Therapeutics Announces €80 Million Series A Financing
Novavax: Agreement to Close by Dec 30 >NVAX
Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX
Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX
Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX
Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX
Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M
Catalent Gains Amid Report Buyer Working on Contact Extensions With Drugmakers
Express News | 'ADA Advises Against Using Compounded GLP-1 RA Medications' - Medscape
Sector Update: Health Care Stocks Decline Premarket Tuesday
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum
Defiance ETFs Launched NVOX, The World's First Single-stock Leveraged ETF For The Pharmaceutical Stock Novo Nordisk
Market Chatter: Novo Nordisk's India Unit Reportedly Pushes for Earlier Wegovy Launch
Concerned about falling behind eli lilly and co (LLY.US) and novo-nordisk a/s (NVO.US), the team in india urges to launch Wegovy in india as soon as possible.
Due to concerns about falling behind competitor eli lilly and co in the potentially huge market in india, the indian team of the danish pharmaceutical giant novo-nordisk a/s has been pushing for the earlier launch of its popular weight-loss drug Wegovy in india.
Novo Nordisk (NVO) Among the Most Profitable Pharmaceutical Stocks Right Now
10 Health Care Stocks With Whale Alerts In Today's Session
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study
Novo Nordisk's Experimental Obesity Drug CagriSema Sales Forecast Overly Optimistic -- Market Talk